<unk>  is indicated for treatment of adults with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.<unk>  was also found to be efficacious in an adolescent who had Pacak–Zhuang syndrome with polycythemia and paragangliomas.
Belzutifan
Ketotifen
Ginkgo biloba
Penmesterol
Bolesatine
Azeloprazole
Epiestriol
Viltolarsen